FilingSEC EDGAR424B5
Allarity Therapeutics Terminates Equity Line of Credit Agreement
· SEC accepted
StageTermination
Filing content
The company terminated its equity line of credit agreement with Tumim Stone Capital effective October 28, ceasing further primary offerings.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…